| |
Read
More
Nattokinaise
Zinc
Undecylenate
Galangal
Cardiovascular
Statistics You Need
to Know
Links
and Suggested
Reading
| Fast
Facts
|
Properties
of Zinc
Undecylenate
- Antifungal
- Antiviral
- Antibacterial
|
| Fast
Facts |
Ailments
where
bacterial,fungal
and
viral
infections
my
play
a
role
- Allergies
- Bronchitis
- Candida
- Cancer
- Cardiovascular
disease
- Chronic
fatigue
- Epstein
Barr
- Gum
disease
- Thrush
- Toe
Nail fungus
- Valley
fever
|
|
|
^
How CircuPrime
Works
Zinc
Undecylenate
By
Kenneth Proefrock,
NMD
Zinc
undecylenate,
C22H38O4Zn,
is the zinc
salt of undecylenic
acid (10-undecenoic
acid), an eleven-carbon
monounsaturated
fatty acid,
C11H20O2. Undecylenic
acid is a naturally
occurring fatty
acid found in
the castor bean
and as a product
of human sweat
glands. It is
produced commercially
through the
vacuum distillation
of castor bean
oil and the
pyrolysis of
ricinoleic acid.1
Since 1949,
the undecylenate
salts have been
used as yeast
and mold inhibitors
in the food
industry, and
in medicine
as topical and
systemic antifungals.
Zinc undecylenate
has been shown
to be an effective
antifungal agent
and is the active
ingredient in
many topical
over-the-counter
antifungal preparations.2,3
Undecylenic
acid has been
shown to be
approximately
six times more
effective in
its antifungal
action than
caprylic acid.
Undecylenate
salts have been
shown to possess
as much as four
times the fungicidal
effect of undecylenic
acid, and may
be over 30 times
more effective
than caprylic
acid.4 These
agents have
also been shown
to be effective
in helping to
maintain a healthy
balance of intestinal
and vaginal
flora.5
In
1945, Wyss published
the first scientific
paper describing
the fungicidal
effects of medium
chain fatty
acids. He showed
a directly proportional
relationship
between the
fungicidal effect
of a fatty acid
and the number
of carbon atoms
in the compound,
up to the point
where the chain
exceeded eleven
carbon atoms,
and solubility
becomes the
limiting factor.6
The
clinical utility
of these medium
chain fatty
acids has been
limited in the
past due to
their irritating
effect on mucus
membranes, in
addition, the
more commonly
used fungicidal
fatty acids
such as caprylic
and undecylenic
acids have an
objectionable
taste and odor
(much like that
of armpit perspiration).
The calcium,
magnesium, zinc
and sodium salts
of these fatty
acids are more
tolerable and
considered more
reasonable and
effective alternatives.
Undecylenate
salts have been
shown to possess
as much as four
times the fungicidal
effect of undecylenic
acid, and may
be over 30 times
more effective
than caprylic
acid.4 The antifungal
effects of the
fatty acid salts
are more sensitive
to pH than the
free fatty acids.
When tested
over a pH range
from 4.5 to
6.0, the minimal
inhibitory concentration
of zinc undecylenate
against Candida
albicans is
200 ppm. In
environments
where the pH
is above 6.0,
the zinc salt
is less effective
than the free
acid, due to
an inability
of the salt
to ionize in
a more alkaline
environment.7
There
are two proposed
mechanisms by
which undecylenic
acid and its
salts exert
their fungicidal
effects. The
first effect
is by inhibiting
endogenous fungal
fatty acid biosynthesis,
which, in turn,
inhibits germ
tube (hyphae)
formation.8
The second mechanism
is through disruption
of cell cytoplasm
pH by acting
as proton carriers.9
Some
accepted therapeutic
roles for zinc
undecylenate
Vaginal/Gastrointestinal
Candidiasis
In
1977, a study
published in the
Journal of the
American Medical
Association found
a direct correlation
between vaginal
yeast infections
and simultaneous
overgrowth of
Candida in the
digestive tract.10
As early as 1954,
undecylenic acid
was shown to be
fungicidal against
Candida albicans,
thus helping achieve
a healthy balance
of normal vaginal
and intestinal
flora.5
Thrush
Since
undecylenate salts
have a systemic
effect, oral administration
can inhibit or
even prevent oral
candidiasis, also
known as thrush.
Milk ducts are
modified sweat
glands in most
mammals so that
during lactation,
oral administration
of undecylenic
acid or its salts
to nursing mothers
can prevent thrush
in babies.
Dermatomycoses
Zinc
undecylenate is
the active ingredient
in Desenex® cream
and a number of
other over the
counter antifungals.
It is responsible
for the antifungal
effect of these
medications against
such organisms
as Candida albicans,
Trichophyton species,
Epidermophyton
inguinale, and
Microsporum audouini.2,3
A 1980 study of
151 patients with
Tinea pedis demonstrated
that a powder
containing 2-percent
undecylenic acid
and 20-percent
zinc undecylenate
resulted in a
statistically
significant decrease
in infection rate
and symptomatology,
when compared
to patients given
a placebo powder.
Eighty-five patients,
who were culture
positive for Trychophyton
rubrum or Trychophyton
mentagrophytes,
were assigned
to receive the
active powder,
and of these,
88 percent had
negative cultures
after four weeks,
compared to 17
percent of those
treated with placebo
powder. There
were no side effects
or adverse reactions
to the zinc undecylenate
powder.7
Herpes Simplex
Infection
Zinc
undecylenate has
been shown to
have antibacterial
and antiviral
properties; it
is specifically
effective against
the herpes simplex
virus in both
animals and humans.
Two studies, one
using a 20-percent
solution11 and
the other a 15-percent
cream,12 demonstrated
a decrease in
the incidence
and duration of
viral shedding
in subjects inoculated
with herpes simplex
virus. Patients
also experienced
a significant
decrease in pain
and tenderness
at the lesion
site. The antiviral
activity was most
pronounced when
the fatty acid
or its salts were
applied during
the prodromal
stage of outbreak.
Slight side effects
consisting of
local skin irritation
and altered sense
of taste were
experience by
some subjects.11,12
Denture
Stomatitis
Candida
albicans is
considered
to be a major
cause of denture
stomatitis,
inflammation
of the tissues
underlying
dentures.
This organism
exists in
two cellular
morphologies – the
round yeast
form found
in asymptomatic
carrier states
and the branching
hyphal form
found in active
infections.
Resilient
liners are
frequently
used to treat
denture stomatitis,
and in 2000,
McLain et
al demonstrated
that liners
containing
undecylenic
acid completely
inhibited
the conversion
of the yeast
form of Candidaalbicans
to the hyphal
form, thereby
inhibiting
proliferation
of the yeast
and halting
the clinical
presentation
of stomatitis.8
Undecylenic
acid and its
salts have been
shown to have
powerful fungicidal
effects at fairly
small dosages. The
dosages necessary
to achieve therapeutic
benefit are
very safe. The
accepted oral
LD50 for these
compounds is
8.15 gm/kg,3 The typical
therapeutic
dosage range
is 4.5-7.5 mg/kg
or 450-750 mg
undecylenic
acid daily in
three divided
doses.13
References
1.
Perkins, Cruz,
Preparation
of Undecylenic
Acid from Castor
Oil. J Am.
Chem. Soc. 1927;
49:1073.
2. Shapiro
AL, Rothman
S. Undecylenic
acid in the
treatment of
Dermatomycoses.
ArchDermatol
Syphilol 1945;
52:166-171.
3.
O’Neil
M, Sr. Ed. The
Merck Index13th
Ed. 2001:9916.
4.
Peck SM, Rosenfeld
H. The effects
of hydrogen
ion concentration,
fatty acids
and vitamin
C on the growth
of fungi. J
Invest Dermatol
1938; 1:237-265.
5.
Neuhauser I.
Successful treatment
of intestinal
moniliasis with
fatty acid-resin
complex. ArchIntern
Med 1954;
93:53-60.
6.
Wyss BJ, et
al. The fungistatic
and fungicidal
action of fatty
acids and related
compounds. Arch
Biochem 1945;
7:415.
7. Chretien
JH, Esswein
JG, Sharpe LM,
et al. Efficacy
of undecylenic
acid-zinc undecylenate
powder in culture
positive tinea
pedis. Int
JDermatol 1980;
19:51-54.
8.
McLain N, Ascanio
R, Baker C,
et al. Undecylenic
acid inhibits
morphogenesis
ofCandida
albicans.
Antimicrob
Agents Chemother
2000; 44:2873-2875.
9.
Steven S, Hofemyer
JHS. Effects
of ehtnaol,
octanoic and
decanoic acids
on fermentation
and the passive
influx of protons
through the
plasma membrane
of Saccharomyces
cerevisiae.
Appl Microbiol
Biotechnol 1993;
38:356-363.
10.
Miles MR, Olsen
L, Rogers A.
Recurrent vaginal
candidiasis.
JAMA 1977;
238:1836-1837.
11.
Bourne N, Ireland
J, Stanberry
LR, Bernstein
DI. Effect of
undecylenic
acid as a topical
microbicide
against genital
herpes infection
in mice and
guinea pigs.
Antiviral Res1999;
40:139-144.
12.
Shafran SD,
Sacks SL, Aoki
FY, et al. Topical
undecylenic
acid for herpes
simplex labialis:
a multicenter,
placebo-controlled
trial. J
InfectDis 1997;
176:78-83.13.
Anonymous. Undecylenic
Acid Monograph
Alt Med Rev
2002; 7:68-70.
|
|